These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. An unusual fusion gene EML4-ALK in a patient with congenital mesoblastic nephroma. Misove A; Vicha A; Zapotocky M; Malis J; Balko J; Nemeckova T; Szabova J; Kyncl M; Novakova-Kodetova D; Stolova L; Jencova P; Broz P; Krskova L Genes Chromosomes Cancer; 2021 Dec; 60(12):837-840. PubMed ID: 34378283 [TBL] [Abstract][Full Text] [Related]
34. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Knezevich SR; Garnett MJ; Pysher TJ; Beckwith JB; Grundy PE; Sorensen PH Cancer Res; 1998 Nov; 58(22):5046-8. PubMed ID: 9823307 [TBL] [Abstract][Full Text] [Related]
35. Distant metastatic spread of molecularly proven infantile fibrosarcoma of the chest in a 2-month-old girl: case report and review of literature. van Grotel M; Blanco E; Sebire NJ; Slater O; Chowdhury T; Anderson J J Pediatr Hematol Oncol; 2014 Apr; 36(3):231-3. PubMed ID: 24276045 [TBL] [Abstract][Full Text] [Related]
37. A newborn with a large NTRK fusion positive infantile fibrosarcoma successfully treated with larotrectinib. Caldwell KJ; De La Cuesta E; Morin C; Pappo A; Helmig S Pediatr Blood Cancer; 2020 Sep; 67(9):e28330. PubMed ID: 32452122 [TBL] [Abstract][Full Text] [Related]
38. Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia. Kralik JM; Kranewitter W; Boesmueller H; Marschon R; Tschurtschenthaler G; Rumpold H; Wiesinger K; Erdel M; Petzer AL; Webersinke G Diagn Pathol; 2011 Mar; 6():19. PubMed ID: 21401966 [TBL] [Abstract][Full Text] [Related]
39. Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an ETV6-NTRK3 fusion in both components. Xu J; Weisman P Genes Chromosomes Cancer; 2021 Jun; 60(6):447-451. PubMed ID: 33342011 [TBL] [Abstract][Full Text] [Related]
40. Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement. El Demellawy D; Cundiff CA; Nasr A; Ozolek JA; Elawabdeh N; Caltharp SA; Masoudian P; Sullivan KJ; de Nanassy J; Shehata BM Pathology; 2016 Jan; 48(1):47-50. PubMed ID: 27020209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]